{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:02:09Z","timestamp":1777528929030,"version":"3.51.4"},"reference-count":151,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.dld.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T09:01:46Z","timestamp":1498208506000},"page":"947-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases"],"prefix":"10.1016","volume":"49","author":[{"given":"Antonio","family":"Di Sabatino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Frulloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-4911","authenticated-orcid":false,"given":"Marco Vincenzo","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino Roberto","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.06.010_bib0005","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.autrev.2015.08.004","article-title":"New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract","volume":"14","author":"Di Sabatino","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2017.06.010_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: a comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2017.06.010_bib0015","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gutjnl-2012-304224","article-title":"Recent advances in autoimmune pancreatitis: type 1 and type 2","volume":"62","author":"Kamisawa","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0020","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(09)60254-3","article-title":"Coeliac disease","volume":"373","author":"Di Sabatino","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2017.06.010_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12016-010-8218-y","article-title":"Cutting edge issues in autoimmune gastritis","volume":"42","author":"Toh","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.dld.2017.06.010_bib0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrgastro.2013.101","article-title":"Autoimmune atrophic gastritis\u2014pathogenesis, pathology and management","volume":"10","author":"Neumann","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/1097-0142(19930201)71:3<745::AID-CNCR2820710316>3.0.CO;2-1","article-title":"Pernicious anemia and subsequent cancer. A population-based cohort study","volume":"71","author":"Hsing","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2017.06.010_bib0045","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cgh.2012.02.018","article-title":"Common features of patients with autoimmune atrophic gastritis","volume":"10","author":"Miceli","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12026-016-8841-7","article-title":"Pathophysiology and laboratory diagnosis of pernicious anemia","volume":"65","author":"Toh","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.dld.2017.06.010_bib0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00365521.2016.1275771","article-title":"The challenging diagnosis of autoimmune atrophic gastritis","volume":"52","author":"Lenti","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI113344","article-title":"Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach","volume":"81","author":"Karlsson","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2017.06.010_bib0065","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1073\/pnas.87.16.6418","article-title":"The 60- to 90-kDa parietal cell autoantigen associated with autoimmune gastritis is a beta subunit of the gastric H+\/K(+)-ATPase (proton pump)","volume":"87","author":"Toh","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2017.06.010_bib0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/08916939309014648","article-title":"Alpha and beta subunits of the gastric H+\/K+-ATPase are concordantly targeted by parietal cell autoantibodies associated with autoimmune gastritis","volume":"16","author":"Callaghan","year":"1993","journal-title":"Autoimmun"},{"key":"10.1016\/j.dld.2017.06.010_bib0075","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/ajg.2009.231","article-title":"Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency","volume":"104","author":"Lahner","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/08916934.2012.702813","article-title":"Parietal cell antibody identified by ELISA is superior to immunofluorescence, rises with age and is associated with intrinsic factor antibody","volume":"45","author":"Toh","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2017.06.010_bib0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.autrev.2010.08.006","article-title":"Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases","volume":"10","author":"Tozzoli","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2017.06.010_bib0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF03347456","article-title":"Serum autoimmune gastritis markers, pepsinogen I and parietal cell antibodies, in patients with type 1 diabetes mellitus: a 5-year prospective study","volume":"34","author":"Alonso","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.dld.2017.06.010_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.advms.2015.12.004","article-title":"Anti-parietal cell antibodies\u2014diagnostic significance","volume":"61","author":"Rusak","year":"2016","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.dld.2017.06.010_bib0100","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/S1590-8658(16)30076-7","article-title":"Potential autoimmune atrophic gastritis","volume":"48S2","author":"Lenti","year":"2016","journal-title":"Dig Liv Dis"},{"key":"10.1016\/j.dld.2017.06.010_bib0105","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MCG.0000000000000101","article-title":"A laboratory score in the diagnosis of autoimmune atrophic gastritis: a prospective study","volume":"49","author":"Miceli","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0344-0338(99)80041-7","article-title":"Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection","volume":"195","author":"Faller","year":"1999","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.dld.2017.06.010_bib0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.20030530","article-title":"Molecular mimicry between Helicobacter pylori antigens and h+, k+-adenosine triphosphatase in human gastric autoimmunity","volume":"198","author":"Amedei","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0120","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1055-9965.EPI-12-1343","article-title":"Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany","volume":"22","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2017.06.010_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jaut.1995.0009","article-title":"Associated autoimmunity in Addison's disease","volume":"8","author":"Zelissen","year":"1995","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2017.06.010_bib0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000199325","article-title":"Prevalence of autoimmune atrophic gastritis in vitiligo","volume":"34","author":"Zauli","year":"1986","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2017.06.010_bib0135","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood-2005-09-3534","article-title":"Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion","volume":"107","author":"Hershko","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.dld.2017.06.010_bib0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.autrev.2014.01.042","article-title":"Diagnosis and classification of pernicious anemia","volume":"13","author":"Bizzaro","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2017.06.010_bib0145","first-page":"462","article-title":"Autoantibodies in pernicious anemia type I patients recognize sequence 251\u2013256 in human intrinsic factor","volume":"109","author":"Gu\u00e9ant","year":"1997","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.dld.2017.06.010_bib0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0016-5085(19)34006-5","article-title":"Blocking and binding antibodies to intrinsic factor and parietal cell antibody in pernicious anemia","volume":"55","author":"Samloff","year":"1968","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/07853890.2010.523229","article-title":"Are we not over-estimating the prevalence of coeliac disease in the general population","volume":"42","author":"Biagi","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0160","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(71)91499-1","article-title":"Tissue antibodies in dermatitis herpetiformis and adult coeliac disease","volume":"1","author":"Seah","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-3476(84)80074-8","article-title":"Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease","volume":"105","author":"M\u00e4ki","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2017.06.010_bib0170","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1136\/bmj.286.6383.2007","article-title":"Alpha gliadin antibody levels: a serological test for coeliac disease","volume":"286","author":"O'Farrelly","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.dld.2017.06.010_bib0175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1983.tb22220.x","article-title":"IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease","volume":"420","author":"Chorzelski","year":"1983","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.dld.2017.06.010_bib0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0185","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/clinchem\/47.11.2023","article-title":"Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides","volume":"47","author":"Aleanzi","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.dld.2017.06.010_bib0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/gut.47.4.520","article-title":"Immune reaction against the cytoskeleton in coeliac disease","volume":"47","author":"Clemente","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000338284","article-title":"Antibodies to wheat high molecular weight glutenin sub-units in patients with coeliac disease","volume":"159","author":"Ellis","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.dld.2017.06.010_bib0200","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(89)92352-0","article-title":"IgG endomysial antibodies in IgA-deficient patient with coeliac disease","volume":"1","author":"Beutner","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0205","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","article-title":"Diagnosis and management of adult coeliac disease\u2014guidelines from the British Society of Gastroenterology","volume":"63","author":"Ludvigsson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.autrev.2013.10.005","article-title":"IgA deficiency and autoimmunity","volume":"13","author":"Singh","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.dld.2017.06.010_bib0215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gut.34.2.150","article-title":"Clinical and pathological spectrum of coeliac disease\u2014active, silent, latent, potential","volume":"34","author":"Ferguson","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0220","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/003655201750305477","article-title":"Endomysial and tissue transglutaminase antibodies in coeliac sera: a comparison not influenced by previous serological testing","volume":"36","author":"Biagi","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0225","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1155\/2009\/258041","article-title":"The impact of misdiagnosing celiac disease at a referral centre","volume":"23","author":"Biagi","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0230","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2017.06.010_bib0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.04054.x","article-title":"Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases","volume":"159","author":"Ferrara","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2017.06.010_bib0240","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/ajg.2010.276","article-title":"Update on serologic testing in celiac disease","volume":"105","author":"Leffler","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0245","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/gut.35.6.771","article-title":"Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values","volume":"35","author":"Corrao","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0250","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1053\/j.gastro.2005.02.025","article-title":"Follow-up of patients with celiac disease: achieving compliance with treatment","volume":"128","author":"Pietzak","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0255","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2036.2009.04039.x","article-title":"Anti-tissue transglutaminase antibodies in the follow up of adult coeliac disease","volume":"30","author":"Dipper","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2017.06.010_bib0260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00042737-200203000-00017","article-title":"IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease","volume":"14","author":"Kaukinen","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005176-199507000-00012","article-title":"Endomysial antibodies as unreliable marker for slight dietary transgressions in adolescents with coeliac disease","volume":"21","author":"Troncone","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2017.06.010_bib0270","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1572-0241.2000.01838.x","article-title":"Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery","volume":"95","author":"Dickey","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0275","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1753-4887.2004.tb00062.x","article-title":"A milligram of gluten a day keeps the mucosal recovery away","volume":"62","author":"Biagi","year":"2004","journal-title":"Nutr Rev"},{"key":"10.1016\/j.dld.2017.06.010_bib0280","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1017\/S0007114511007367","article-title":"A score that verifies adherence to a gluten-free diet: a cross-sectional, multicentre validation in real clinical life","volume":"108","author":"Biagi","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.dld.2017.06.010_bib0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1309\/AJCPEIILH2C0WFYE","article-title":"The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study","volume":"138","author":"Biagi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.dld.2017.06.010_bib0290","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00005176-198506000-00009","article-title":"Autoimmunity in diarrhoeal disease","volume":"4","author":"Unsworth","year":"1985","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2017.06.010_bib0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(97)01042-8","article-title":"Autoimmune enteropathy and villous atrophy in adults","volume":"350","author":"Corazza","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0300","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/modpathol.2008.161","article-title":"Digestive histopathological presentation of IPEX syndrome","volume":"22","author":"Patey-Mariaud de Serre","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.dld.2017.06.010_bib0305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0140-6736(93)91531-P","article-title":"Gut epithelial cell autoantibodies in AIDS pathogenesis","volume":"342","author":"Mart\u00edn-Villa","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0310","series-title":"Coeliac disease","first-page":"131","article-title":"Coeliac disease and autoimmune enteropathy","author":"Walker-Smith","year":"1991"},{"key":"10.1016\/j.dld.2017.06.010_bib0315","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/modpathol.2013.150","article-title":"Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency disorders","volume":"27","author":"Singhi","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.dld.2017.06.010_bib0320","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0140-6736(82)92076-1","article-title":"Autoantibodies against gut epithelium in a child with small intestinal enteropathy","volume":"1","author":"Walker-Smith","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0325","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1651-2227.1985.tb11011.x","article-title":"Fatal unresponsive villous atrophy of the jejunum, connective tissue disease and diabetes in a girl with intestinal epithelial cell antibody","volume":"74","author":"Savilahti","year":"1985","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.dld.2017.06.010_bib0330","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"Adult autoimmune enteropathy: Mayo Clinic Rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0335","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/ajg.2009.511","article-title":"Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy?","volume":"104","author":"Biagi","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0340","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.gastro.2006.04.030","article-title":"Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease","volume":"131","author":"Dotan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ajg.2012.363","article-title":"Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis","volume":"108","author":"Nanda","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0350","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn's disease","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0091-6749(05)80067-3","article-title":"A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease","volume":"86","author":"Saxon","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.dld.2017.06.010_bib0360","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ibd.21903","article-title":"Serological antibodies in inflammatory bowel disease: a systematic review","volume":"18","author":"Prideaux","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2017.06.010_bib0365","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/gast.1996.v110.pm8964407","article-title":"Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup","volume":"110","author":"Vasiliauskas","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0370","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","article-title":"Antibodies to CBir1 flagellin define a unique responsethat is associated independently with complicated Crohn's disease","volume":"128","author":"Targan","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0375","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/ajg.2010.95","article-title":"Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis","volume":"105","author":"J\u00fcrgens","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0380","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/apt.12274","article-title":"Meta-analysis: serological markers and the risk of acute and chronic pouchitis","volume":"37","author":"Singh","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2017.06.010_bib0385","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ibd.22862","article-title":"Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis","volume":"18","author":"Kaul","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2017.06.010_bib0390","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1007\/s10620-012-2244-y","article-title":"Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2017.06.010_bib0395","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MPG.0000000000001244","article-title":"Assessment of fecal ASCA measurement as a biomarker of Crohn disease in pediatric patients","volume":"64","author":"Tang","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2017.06.010_bib0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ibd.21046","article-title":"Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn\u2019s disease behavior","volume":"16","author":"Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2017.06.010_bib0405","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MEG.0000000000000102","article-title":"Serum antibodies to microbial antigens for Crohn's disease progression: a meta-analysis","volume":"26","author":"Xiong","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0410","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPG.0b013e31812f7f6e","article-title":"Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis","volume":"45","author":"Davis","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2017.06.010_bib0415","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ecco-jcc\/jjw021","article-title":"Concordance in anti-OmpC and anti-I2 indicate the influence of genetic predisposition: results of a European Study of Twins with Crohn's Disease","volume":"10","author":"Amcoff","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2017.06.010_bib0420","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/apt.13641","article-title":"Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis","volume":"43","author":"Choung","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2017.06.010_bib0425","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2012-302717","article-title":"Serological markers predict inflammatory bowel disease years before the diagnosis","volume":"62","author":"van Schaik","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0430","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/2050640616640160","article-title":"Biomarkers of intestinal fibrosis\u2014one step towards clinical trials for stricturing inflammatory bowel disease","volume":"4","author":"Giuffrida","year":"2016","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2017.06.010_bib0435","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/gutjnl-2013-305259","article-title":"The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab","volume":"63","author":"Ungar","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0440","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0445","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpba.2013.01.031","article-title":"Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay","volume":"78-79","author":"Wang","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.dld.2017.06.010_bib0450","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/apt.12869","article-title":"Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease","volume":"40","author":"Mazor","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2017.06.010_bib0455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cgh.2014.07.029","article-title":"Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab","volume":"13","author":"Yanai","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0460","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/gutjnl-2014-308099","article-title":"The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study","volume":"65","author":"Yarur","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0465","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2015.07.002","article-title":"Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease","volume":"149","author":"Biancheri","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0470","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0475","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/jcp.55.12.906","article-title":"Detection of liver\u2013kidney microsomal type 1 antibody using molecular based immunoassay","volume":"55","author":"Kerkar","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2017.06.010_bib0480","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology; current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0485","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2017.06.010_bib0490","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2006-927280","article-title":"Steroid treatment for severe acute cryptogenic hepatitis","volume":"45","author":"Potthoff","year":"2007","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0495","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0500","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","article-title":"Behavior and significance of autoantibodies in type 1 autoimmune hepatitis","volume":"30","author":"Czaja","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0505","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/0891693021000056721","article-title":"Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease","volume":"35","author":"Gregorio","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2017.06.010_bib0510","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0515","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0520","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/00365521.2014.946083","article-title":"Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands","volume":"49","author":"van Gerven","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0525","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jhep.2010.12.012","article-title":"Autoimmune hepatitis","volume":"55","author":"Lohse","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0530","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver diseases","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0535","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1572-0241.2006.00830.x","article-title":"Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis","volume":"101","author":"Frenzel","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0540","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08916930701619896","article-title":"Diagnostic accuracy of four different immunological methods for detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders","volume":"41","author":"Villalta","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2017.06.010_bib0545","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.2006.039404","article-title":"Diagnostic relevance of antifilamentous actin antibodies in autoimmune hepatitis","volume":"60","author":"Liaskos","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2017.06.010_bib0550","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.06.010_bib0555","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0168-8278(96)80228-5","article-title":"Non-organ specific autoantibodies in children with chronic hepatitis C","volume":"25","author":"Bortolotti","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0560","first-page":"643","article-title":"Liver cytosolic antigen\u2013antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"116","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0565","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00042737-200201000-00007","article-title":"Increased incidence of anti-LKM autoantibodies in a consecutive cohort of HCV patients from central Greece","volume":"14","author":"Dalekos","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0570","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2009.02.020","article-title":"Clinical features and effects of antiviral therapy on anti-liver\/kidney microsomal antibody type1 positive chronic hepatitis C","volume":"50","author":"Ferri","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0575","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6 (193\u2013212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal antibody type-1 positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2017.06.010_bib0580","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autontibodies in autoimmune hepatitis","volume":"355","author":"Weis","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0585","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1173755","article-title":"The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation","volume":"325","author":"Palioura","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.dld.2017.06.010_bib0590","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardized SLA\/LP immunoassay: specificity for autoimmune hepatitis, wordwide occurrence, clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2017.06.010_bib0595","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1016\/S0168-8278(07)62258-2","article-title":"Antibody responses specific for soluble liver antigen co-occur with Ro-52 autoantibodies in patients with autoimmune hepatitis","volume":"46","author":"Liaskos","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0600","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0016-5085(95)90215-5","article-title":"High titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis","volume":"108","author":"Targan","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0605","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510250510","article-title":"Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis","volume":"25","author":"Zauli","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.06.010_bib0610","doi-asserted-by":"crossref","first-page":"e92267","DOI":"10.1371\/journal.pone.0092267","article-title":"Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to soluble liver antigen\/liver pancreas in autoimmune hepatitis","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.dld.2017.06.010_bib0615","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0620","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0625","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimithocondrial antibodies: chipping away at AMA\u2013negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.06.010_bib0630","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mithocondrial antibodies activates innate immune response in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.06.010_bib0635","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2017.06.010_bib0640","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1089-3261(03)00104-1","article-title":"Antimitochondrial and other autoantibodies","volume":"7","author":"Bogdanos","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2017.06.010_bib0645","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brein","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.06.010_bib0650","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semi Liver Dis"},{"key":"10.1016\/j.dld.2017.06.010_bib0655","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2017.06.010_bib0660","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"Atypical p-ANCA in IBD and hepatobiliary disorders react with 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0665","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2249.2001.01649.x","article-title":"Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver disease from anti-neutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy","volume":"126","author":"Terjung","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.dld.2017.06.010_bib0670","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of anti-neutrophil cytoplsmic antibodies (ANCA) in autoimmune liver disease","volume":"32","author":"Roozendal","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0675","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0680","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0168-8278(94)80258-0","article-title":"The immunogenetic basis for anti-neutrophil cytoplasmic antibody production in primary sclerosing cholangitis and ulcerative colitis","volume":"21","author":"Mahal","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0685","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/gut.33.5.657","article-title":"Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis","volume":"33","author":"Seibold","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.06.010_bib0690","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1440-1746.1994.tb01214.x","article-title":"Anti-neutrophil cytoplasmic antibodies: a prognostic indicator in primary sclerosing cholangitis","volume":"9","author":"Pokorny","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0695","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0168-8278(05)80604-X","article-title":"A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment","volume":"21","author":"Lo","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0700","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2017.06.010_bib0705","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatits: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.dld.2017.06.010_bib0710","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/ajg.2009.327","article-title":"Autoimmune pancreatitis: differences between the focal and the diffuse forms in 87 patients","volume":"104","author":"Frulloni","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0715","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0720","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.gastro.2015.03.010","article-title":"Recent advances in autoimmune pancreatitis","volume":"149","author":"Hart","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.06.010_bib0725","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011","volume":"44","author":"Kanno","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.dld.2017.06.010_bib0730","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00535-008-2190-9","article-title":"Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis","volume":"43","author":"Okazaki","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2017.06.010_bib0735","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13317-011-0024-x","article-title":"Differentiation of autoimmune pancreatitis from pancreas cancer: utility of anti-amylase and anti-carbonic anhydrase II autoantibodies","volume":"3","author":"S\u00e1nchez-Casta\u00f1\u00f3n","year":"2011","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.dld.2017.06.010_bib0740","first-page":"237","article-title":"Lactoferrin in chronic pancreatitis","volume":"10","author":"Jin","year":"2009","journal-title":"JOP"},{"key":"10.1016\/j.dld.2017.06.010_bib0745","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.mpa.0000226881.48204.fd","article-title":"Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis","volume":"33","author":"Asada","year":"2006","journal-title":"Pancreas"},{"key":"10.1016\/j.dld.2017.06.010_bib0750","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa0903068","article-title":"Identification of a novel antibody associated with autoimmune pancreatitis","volume":"361","author":"Frulloni","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2017.06.010_bib0755","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/ajg.2016.241","article-title":"Testing for anti-PBP antibody is not useful in diagnosing autoimmune pancreatitis","volume":"111","author":"Buijs","year":"2016","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817309404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817309404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T19:17:24Z","timestamp":1602357444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817309404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":151,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1590865817309404"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.06.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}